Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1979 1
1980 1
1987 1
1988 2
1989 1
1990 1
1991 2
1993 1
1994 2
1995 1
1996 1
1997 3
1998 3
1999 1
2000 5
2001 3
2002 10
2003 3
2004 14
2005 7
2006 7
2007 8
2008 12
2009 7
2010 7
2011 12
2012 11
2013 16
2014 24
2015 11
2016 11
2017 17
2018 14
2019 13
2020 23
2021 30
2022 27
2023 22
2024 13

Text availability

Article attribute

Article type

Publication date

Search Results

305 results

Results by year

Filters applied: . Clear all
Page 1
Dabigatran versus warfarin in patients with atrial fibrillation.
Connolly SJ, Ezekowitz MD, Yusuf S, Eikelboom J, Oldgren J, Parekh A, Pogue J, Reilly PA, Themeles E, Varrone J, Wang S, Alings M, Xavier D, Zhu J, Diaz R, Lewis BS, Darius H, Diener HC, Joyner CD, Wallentin L; RE-LY Steering Committee and Investigators. Connolly SJ, et al. N Engl J Med. 2009 Sep 17;361(12):1139-51. doi: 10.1056/NEJMoa0905561. Epub 2009 Aug 30. N Engl J Med. 2009. PMID: 19717844 Free article. Clinical Trial.
The effect of fish oil supplementation on resistance training-induced adaptations.
Heileson JL, Machek SB, Harris DR, Tomek S, de Souza LC, Kieffer AJ, Barringer ND, Gallucci A, Forsse JS, Funderburk LK. Heileson JL, et al. J Int Soc Sports Nutr. 2023 Dec;20(1):2174704. doi: 10.1080/15502783.2023.2174704. J Int Soc Sports Nutr. 2023. PMID: 36822153 Free PMC article. Clinical Trial.
An a priori alpha-level of 0.05 was used to determine statistical significance and Cohen's d was used to quantify effect sizes (ES). RESULTS: Twenty-one of 28 male and female participants (FOS, n = 10 [4 withdrawals]; PL, n = 11 [3 withdrawals]) completed the 10-week progr …
An a priori alpha-level of 0.05 was used to determine statistical significance and Cohen's d was used to quantify effect sizes (ES). …
Pharmacological perturbation of the phase-separating protein SMNDC1.
Enders L, Siklos M, Borggräfe J, Gaussmann S, Koren A, Malik M, Tomek T, Schuster M, Reiniš J, Hahn E, Rukavina A, Reicher A, Casteels T, Bock C, Winter GE, Hannich JT, Sattler M, Kubicek S. Enders L, et al. Nat Commun. 2023 Aug 16;14(1):4504. doi: 10.1038/s41467-023-40124-0. Nat Commun. 2023. PMID: 37587144 Free PMC article.
This condensation behavior is driven by the unstructured C-terminal region of SMNDC1, depends on RNA interaction and can be recapitulated in vitro. Inhibitors of the protein's Tudor domain drastically alter protein-protein interactions and subcellular localization, causing …
This condensation behavior is driven by the unstructured C-terminal region of SMNDC1, depends on RNA interaction and can be recapitulated in …
BiGRUD-SA: Protein S-sulfenylation sites prediction based on BiGRU and self-attention.
Zhang T, Jia J, Chen C, Zhang Y, Yu B. Zhang T, et al. Comput Biol Med. 2023 Sep;163:107145. doi: 10.1016/j.compbiomed.2023.107145. Epub 2023 Jun 8. Comput Biol Med. 2023. PMID: 37336062
However, there are many restrictions on the experimental identification of S-sulfenylation sites. Therefore, predicting S-sulfoylation sites by computational methods is fundamental to studying protein function and related biological mechanisms. ...Finally, we input …
However, there are many restrictions on the experimental identification of S-sulfenylation sites. Therefore, predicting S-sulf …
Neratinib after trastuzumab-based adjuvant therapy in HER2-positive breast cancer (ExteNET): 5-year analysis of a randomised, double-blind, placebo-controlled, phase 3 trial.
Martin M, Holmes FA, Ejlertsen B, Delaloge S, Moy B, Iwata H, von Minckwitz G, Chia SKL, Mansi J, Barrios CH, Gnant M, Tomašević Z, Denduluri N, Šeparović R, Gokmen E, Bashford A, Ruiz Borrego M, Kim SB, Jakobsen EH, Ciceniene A, Inoue K, Overkamp F, Heijns JB, Armstrong AC, Link JS, Joy AA, Bryce R, Wong A, Moran S, Yao B, Xu F, Auerbach A, Buyse M, Chan A; ExteNET Study Group. Martin M, et al. Lancet Oncol. 2017 Dec;18(12):1688-1700. doi: 10.1016/S1470-2045(17)30717-9. Epub 2017 Nov 13. Lancet Oncol. 2017. PMID: 29146401 Clinical Trial.
Utility of transcranial ultrasound in predicting Alzheimer's disease risk.
Tomek A, Urbanová B, Hort J. Tomek A, et al. J Alzheimers Dis. 2014;42 Suppl 4:S365-74. doi: 10.3233/JAD-141803. J Alzheimers Dis. 2014. PMID: 25298200 Review.
Alzheimer's disease (AD) is a progressive, neurodegenerative disease characterized by an increasing incidence. ...
Alzheimer's disease (AD) is a progressive, neurodegenerative disease characterized by an increasing incidence. ...
Compartmentalized cAMP signalling and control of cardiac rhythm.
Tomek J, Zaccolo M. Tomek J, et al. Philos Trans R Soc Lond B Biol Sci. 2023 Jun 19;378(1879):20220172. doi: 10.1098/rstb.2022.0172. Epub 2023 May 1. Philos Trans R Soc Lond B Biol Sci. 2023. PMID: 37122225 Free PMC article. Review.
Effect of Asymptomatic and Symptomatic COVID-19 on Acute Ischemic Stroke Revascularization Outcomes.
Strambo D, Marto JP, Ntaios G, Nguyen TN, Michel P; Global COVID-19 Stroke Registry. Strambo D, et al. Stroke. 2024 Jan;55(1):78-88. doi: 10.1161/STROKEAHA.123.043899. Epub 2023 Dec 22. Stroke. 2024. PMID: 38134260 Free PMC article.
Only in patients with symptomatic infections, we observed a significant increase in mortality at 24 hours (COVID-controls, 1.3%; S-COVID, 4.8%; aOR, 2.97 [95% CI, 1.76-5.03]) and 3 months (COVID-controls, 19.5%; S-COVID, 40%; aOR, 2.64 [95% CI, 2.06-3.37]). ...CONCL …
Only in patients with symptomatic infections, we observed a significant increase in mortality at 24 hours (COVID-controls, 1.3%; S-CO …
Paralog-dependent isogenic cell assay cascade generates highly selective SLC16A3 inhibitors.
Dvorak V, Casiraghi A, Colas C, Koren A, Tomek T, Offensperger F, Rukavina A, Tin G, Hahn E, Dobner S, Frommelt F, Boeszoermenyi A, Bernada V, Hannich JT, Ecker GF, Winter GE, Kubicek S, Superti-Furga G. Dvorak V, et al. Cell Chem Biol. 2023 Aug 17;30(8):953-964.e9. doi: 10.1016/j.chembiol.2023.06.029. Epub 2023 Jul 28. Cell Chem Biol. 2023. PMID: 37516113 Free PMC article.
305 results